络活喜循证之路1课件.pptVIP

* 这是ALLHAT 的亚组分析，结果显示，对于基线有冠心病的患者，服用络活喜或赖诺普利，其累计冠心病事件发生率并无差异，也就是说络活喜在冠心病二级预防方面的疗效与ACEI相似 * 2 3 * * Byington RP, Miller ME, Herrington D, et al, for the PREVENT Investigators. Rationale, design, and baseline characteristics of the Prospective Randomized Evaluation of the Vascular Effects of Norvasc Trial (PREVENT). Am J Cardiol. 1997;80:1087-1090. Pitt B, Byington RP, Furberg CD, et al, for the PREVENT Investigators. Effect of amlodipine on the progression of atherosclerosis and the occurrence of clinical events. Circulation. 2000. In press. Slide 40 Slide 47 Pitt B, Byington RP, Furberg CD